|
|
BioSig Tech. (BSGM) & Electrophysiology Sector (related stock BSGM)
|
|
||
One cent max ... is wiw: opening of the second wave to be countered?While BSGM is "hosting" the call tomorrow, there is logic that Mayo Clinic would be center-stage for the actual "reveal" of the trial they initiated and managed. Dr. Badley is the heavyweight to this call. I cannot envision a better second wave backdrop for garnering attention to an effective oral anti-viral. For a microcap, BioSig has impressive skillsets at timely and effective PRs ... I expect a solid story will be heard. Beyond efficacy and safety data, hearing about the next series of imminent "warp speed" actions in the ViralClear plan is expected. We know they have pre-production contracts for molecule manufacturing (Albany Molecular) and production of liquid and gelpak dosing (Catalent). I anticipate that the FDA has a timely and very important card in their hand that will be played. If an second anti-viral is "emergency approved" and it is oral ... bright light will be shown in every dark economic and medical forecast. All the best. For the record, KL's "later in the summer" ends today, 9/21. He only missed by one day. |
return to message board, top of board |